A Phase 2 Trial of AU-011 Via Suprachoroidal Administration with a Dose Escalation Phase (Open-label, Ascending Single and Repeat Dose) and a Randomized, Masked Dose Expansion Phase Designed to Evaluate the Safety and Efficacy of AU-011 in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma
Michael Altaweel
TALON
A 64-Week, Two-Arm, Randomized, Double-Masked, Multi-Center, Phase IIIb Study Assessing the Efficacy and Safety of Brolucizumab 6 mg Compared to Aflibercept 2 mg in a Treat-To-Control Regimen in Patients with Neovascular Age-Related Macular Degeneration (TALON)
Alcohol Pads and Nonsterile Gloves in Preparation of Aflibercept.
PubMed ID: 32768034 Author(s): Regan KA, Gottlieb JL, Altaweel MM, Mititelu M, Blodi BA, Nork TM, Stepien KE, Chang JS. Alcohol pads and nonsterile gloves in preparation of aflibercept. Ophthalmol Retina. 2020 Aug;4(8):853-854. doi: 10.1016/j.oret.2020.04.006. …
Bilateral Globe Penetration From Electromyography Electrode Placement for Intraoperative Neurophysiologic Monitoring.
PubMed ID: 37008380 Author(s): Bowen RC, Possin ME, Altaweel MM. Bilateral Globe Penetration From Electromyography Electrode Placement for Intraoperative Neurophysiologic Monitoring. J Vitreoretin Dis. 2019 Oct 16;4(2):136-138. doi: 10.1177/2474126419868888. eCollection 2020 Mar-Apr. PMID 37008380 Journal: …
TWO CASES OF ACUTE RETINAL NECROSIS DUE TO VARICELLA ZOSTER DESPITE PRIOR SHINGLES VACCINATION.
PubMed ID: 28291069 Author(s): Weinlander EJ, Wang AL, Jaru-Ampornpan P, Altaweel MM, Nork TM. Two cases of acute retinal necrosis due to varicella zoster despite prior shingles vaccination. Retin Cases Brief Rep. 2019 Summer;13(3):241-243. doi: …
RAVEN
An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients with Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion
RAPTOR
An Eighteen-Month, Two-Arm, Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients with Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)
KINGFISHER
A 12-Month, 2-Arm, Randomized, Double-Masked, Multicenter Phase III Study Assessing the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients with Visual Impairment Due to Diabetic Macular Edema (KINGFISHER)
KESTREL
A Two-year, Three-arm, Randomized, Double-masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Adult Patients with Visual Impairment Due to Diabetic Macular Edema (KESTREL)